Ticker: CNTB

Connect Biopharma Holdings Limited (NASDAQ: CNTB) - quick company snapshot and income-statement takeaways. What's happening inside the company * Clinical progress: presented supportive clinical and preclinical rademikibart data at major conferences; initiated two Phase 2 acute-exacerbation trials...

Company Overview: Connect Biopharma Holdings Limited (NASDAQ: CNTB), based in San Diego, California, is a clinical-stage biopharmaceutical company focusing on developing rademikibart, an antibody aimed at treating asthma and chronic obstructive pulmonary disease (COPD). Recent Developments: Marc...